Volume 11, Issue 3 (2025)
Pharm Biomed Res 2025, 11(3): 271-276 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hosseini S H, Ghazvini H, Tamijani S M S, Rafaiee R. Urinary Incontinence During Sleep Associated With Buspirone: A Case Report. Pharm Biomed Res 2025; 11 (3) :271-276
URL: http://pbr.mazums.ac.ir/article-1-693-en.html
URL: http://pbr.mazums.ac.ir/article-1-693-en.html
Seyed Hamzeh Hosseini1 
, Hamed Ghazvini2 , Seyedeh Masoumeh Seyedhosseini Tamijani2 , Raheleh Rafaiee *3
, Hamed Ghazvini2 , Seyedeh Masoumeh Seyedhosseini Tamijani2 , Raheleh Rafaiee *3
1- Department of Psychiatry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
2- Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
3- Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran. & Psychiatry and Behavioral Sciences Research Center, Addiction Research Institute, Mazandaran University of Medical Sciences, Sari, Iran.
2- Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
3- Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran. & Psychiatry and Behavioral Sciences Research Center, Addiction Research Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract: (43 Views)
Background: Buspirone is an anxiolytic medication that selectively alleviates anxiety without the anticonvulsant, sedative, or muscle-relaxant effects associated with benzodiazepine. To the best of our knowledge, case reports of nocturnal urinary incontinence in buspirone users have not yet been published.
Case Report: We report a 52-year-old female patient with urinary incontinence during sleep (once or twice a week) associated with buspirone (10 mg/day). The patient’s nocturnal enuresis problem disappeared immediately after the discontinuation of buspirone.
Conclusion: The mechanism underlying this effect is known. These medications influence neurotransmitter systems that modulate bladder control, altering micturition patterns. Antidepressants affect central nervous system pathways that regulate bladder function, potentially decreasing inhibitory control and increasing detrusor muscle sensitivity. Reporting rare drug side effects is crucial for enhancing patient safety and improving pharmacovigilance.
Case Report: We report a 52-year-old female patient with urinary incontinence during sleep (once or twice a week) associated with buspirone (10 mg/day). The patient’s nocturnal enuresis problem disappeared immediately after the discontinuation of buspirone.
Conclusion: The mechanism underlying this effect is known. These medications influence neurotransmitter systems that modulate bladder control, altering micturition patterns. Antidepressants affect central nervous system pathways that regulate bladder function, potentially decreasing inhibitory control and increasing detrusor muscle sensitivity. Reporting rare drug side effects is crucial for enhancing patient safety and improving pharmacovigilance.
Type of Study: case report |
Subject:
Clinical Pharmacy
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
